Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
iShares MSCI Japan ETF
EWJ
$21.9B
| $6.24M | ﹤0.01% |
106,345
+1,943
| +2% | +$111K |
|
1402
Sabesp
SBS
$19.1B
| $6.23M | ﹤0.01% |
3,206,816
| – | – |
|
1403
Healthcare Realty
HR
$7.28B
| $6.21M | ﹤0.01% |
321,350
-97,316
| -23% | -$1.96M |
|
|
MGI
1404
DELISTED
MoneyGram International, Inc. New
MGI
| $6.21M | ﹤0.01% |
595,708
-1,046,935
| -64% | -$11.3M |
|
|
SAGE
1405
DELISTED
Sage Therapeutics
SAGE
| $6.17M | ﹤0.01% |
147,062
+50,739
| +53% | +$2.18M |
|
1406
Americold
COLD
$4.02B
| $6.12M | ﹤0.01% |
215,088
-50,078
| -19% | -$1.49M |
|
1407
SouthState Bank Corp
SSB
$10.2B
| $6.08M | ﹤0.01% |
85,367
-86,809
| -50% | -$6.76M |
|
1408
Vistra
VST
$50B
| $6.06M | ﹤0.01% |
252,465
+1,677
| +0.7% | +$38.9K |
|
1409
CALL
Warner Bros
WBD
$65.9B
| $6.04M | ﹤0.01% |
400,000
+130,800
| +49% | +$1.86M |
|
|
PLL
1410
CALL
DELISTED
Piedmont Lithium
PLL
| $6M | ﹤0.01% |
+100,000
| New | +$6.07M |
|
1411
ONE Gas
OGS
$4.87B
| $6M | ﹤0.01% |
75,690
+57,354
| +313% | +$4.55M |
|
1412
Qualys
QLYS
$5.1B
| $5.97M | ﹤0.01% |
45,934
+26,984
| +142% | +$3.16M |
|
1413
Fidelity National Financial
FNF
$13.9B
| $5.97M | ﹤0.01% |
170,958
-34,731
| -17% | -$1.37M |
|
1414
PUT
Biogen
BIIB
$30B
| $5.95M | ﹤0.01% |
21,400
-99,100
| -82% | -$27.4M |
|
1415
Stem
STEM
$48.4M
| $5.93M | ﹤0.01% |
52,323
-13,897
| -21% | -$2.36M |
|
1416
OGE Energy
OGE
$9.78B
| $5.93M | ﹤0.01% |
157,408
+128,501
| +445% | +$4.83M |
|
1417
MKS Inc
MKSI
$20.1B
| $5.92M | ﹤0.01% |
66,821
+18,845
| +39% | +$1.8M |
|
1418
Travel + Leisure Co
TNL
$4.66B
| $5.92M | ﹤0.01% |
151,051
-52,878
| -26% | -$2.14M |
|
1419
CALL
Abercrombie & Fitch
ANF
$4.42B
| $5.91M | ﹤0.01% |
213,000
+183,500
| +622% | +$5.11M |
|
|
AYX
1420
PUT
DELISTED
Alteryx Inc
AYX
| $5.88M | ﹤0.01% |
100,000
| – | – |
|
1421
BioCryst Pharmaceuticals
BCRX
$2.28B
| $5.86M | ﹤0.01% |
703,173
+218,681
| +45% | +$2.11M |
|
1422
United Microelectronic
UMC
$47.7B
| $5.86M | ﹤0.01% |
668,811
-732,412
| -52% | -$5.93M |
|
1423
UGI
UGI
$7.74B
| $5.86M | ﹤0.01% |
168,514
-14,822
| -8% | -$562K |
|
|
SVC
1424
Service Properties Trust
SVC
$1.04B
| $5.83M | ﹤0.01% |
117,023
+942
| +0.8% | +$43.6K |
|
1425
CALL
Synchrony
SYF
$24.7B
| $5.82M | ﹤0.01% |
200,000
-28,800
| -13% | -$967K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.